AU2002222075A1 - Mutated immunogenic peptides derived from r9m, polynucleotides coding for same and therapeutic uses thereof - Google Patents

Mutated immunogenic peptides derived from r9m, polynucleotides coding for same and therapeutic uses thereof

Info

Publication number
AU2002222075A1
AU2002222075A1 AU2002222075A AU2207502A AU2002222075A1 AU 2002222075 A1 AU2002222075 A1 AU 2002222075A1 AU 2002222075 A AU2002222075 A AU 2002222075A AU 2207502 A AU2207502 A AU 2207502A AU 2002222075 A1 AU2002222075 A1 AU 2002222075A1
Authority
AU
Australia
Prior art keywords
same
peptides derived
therapeutic uses
immunogenic peptides
polynucleotides coding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002222075A
Inventor
Huseyin Firat
Pierre Langlade-Demoyen
Francois Lemonnier
Pierre Rohrlich
Etienne Vilmer
Patricia Yotnda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Assistance Publique Hopitaux de Paris APHP
Institut Pasteur de Lille
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Assistance Publique Hopitaux de Paris APHP
Institut Pasteur de Lille
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assistance Publique Hopitaux de Paris APHP, Institut Pasteur de Lille, Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Assistance Publique Hopitaux de Paris APHP
Publication of AU2002222075A1 publication Critical patent/AU2002222075A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002222075A 2000-12-01 2001-11-29 Mutated immunogenic peptides derived from r9m, polynucleotides coding for same and therapeutic uses thereof Abandoned AU2002222075A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA2,325,666 2000-12-01
CA 2325666 CA2325666A1 (en) 2000-12-01 2000-12-01 Immunogenic mutated peptides derived from r9m, polynucleotides, coding polynucleotides and their therapeutic uses
PCT/FR2001/003779 WO2002044202A2 (en) 2000-12-01 2001-11-29 Mutated immunogenic peptides derived from r9m, polynucleotides coding for same and therapeutic uses thereof

Publications (1)

Publication Number Publication Date
AU2002222075A1 true AU2002222075A1 (en) 2002-06-11

Family

ID=4167609

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002222075A Abandoned AU2002222075A1 (en) 2000-12-01 2001-11-29 Mutated immunogenic peptides derived from r9m, polynucleotides coding for same and therapeutic uses thereof

Country Status (5)

Country Link
US (2) US7476719B2 (en)
EP (1) EP1337556B1 (en)
AU (1) AU2002222075A1 (en)
CA (1) CA2325666A1 (en)
WO (1) WO2002044202A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009034553A1 (en) * 2009-07-23 2011-01-27 Oerter, Detlef, Dr. Vaccine for the prevention of acute lymphoblastic leukemia in children
US9243035B2 (en) * 2013-11-26 2016-01-26 Nymox Corporation Peptides effective in the treatment of conditions requiring the removal or destruction of cells
US11628202B2 (en) 2015-07-24 2023-04-18 Nymox Corporation Methods of reducing the need for surgery in patients suffering from benign prostatic hyperplasia
US10183058B2 (en) 2016-06-17 2019-01-22 Nymox Corporation Method of preventing or reducing the progression of prostate cancer
US10172910B2 (en) 2016-07-28 2019-01-08 Nymox Corporation Method of preventing or reducing the incidence of acute urinary retention
US10532081B2 (en) 2016-09-07 2020-01-14 Nymox Corporation Method of ameliorating or preventing the worsening or the progression of symptoms of BPH
US10335453B2 (en) 2017-03-01 2019-07-02 Nymox Corporation Compositions and methods for improving sexual function
CN116836231B (en) * 2023-06-30 2024-02-13 深圳大学总医院 New antigen peptide of t (8; 21) AML and application thereof

Also Published As

Publication number Publication date
US7476719B2 (en) 2009-01-13
CA2325666A1 (en) 2002-06-01
EP1337556B1 (en) 2019-03-27
US20090324556A1 (en) 2009-12-31
EP1337556A2 (en) 2003-08-27
US8303957B2 (en) 2012-11-06
US20040018205A1 (en) 2004-01-29
WO2002044202A3 (en) 2003-01-03
WO2002044202A2 (en) 2002-06-06

Similar Documents

Publication Publication Date Title
AU2002320314A1 (en) Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
AU2487300A (en) Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
ZA200407868B (en) 17alpha-Alkyl-17beta-oxy-estratrienes, uses thereof and pharmaceutical preparations.
AU5850798A (en) Polynucleotides encoding proexendin, and methods and uses thereof
AU5784000A (en) Ecarin polypeptides, polynucleotides encoding ecarin, and methods for use thereof
AU6246199A (en) Human interleukin-b50, therapeutic uses
AU2002316578A1 (en) Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
AU2001259837A1 (en) Therapeutic pore-forming peptides
AU2001295483A1 (en) Solid peptide preparations for inhalation, and the production thereof
AU2002222075A1 (en) Mutated immunogenic peptides derived from r9m, polynucleotides coding for same and therapeutic uses thereof
AU2003228863A1 (en) Immunogenic peptides
AU2002353764A1 (en) Staphylococci surface-exposed immunogenic polypeptides
AU4001000A (en) Dwf4 polynucleotides, polypeptides and uses thereof
AU2002327676A1 (en) Novel polynucleotides and proteins encoded thereby
AU2002220924A1 (en) Antibodies, peptides, analogs and uses thereof
AU2001280464A1 (en) C1q-related factor, homologous polypeptides and therapeutic uses thereof
IL161234A0 (en) Ngzipa, ngzipd, pgzipa and pgzipd polynucleotides and polypeptides and uses thereof
AU2001257378A1 (en) 23949 and 32391, human ion channels and uses thereof
AU5633601A (en) Cross-linked polymers useful for the pharmaceutical, medical and cosmetic uses
AU2001247460A1 (en) 18615 and 48003, human ion channels and uses therefor
AU2003234717A1 (en) Novel polynucleotides encoding the human citron kinase polypeptide, bmsnkc 0020/0021
EP1576099A3 (en) Novel polynucleotides encoding the human citron kinase polypeptide, bmsnkc 0020/0021
WO2002072611A8 (en) Novel human egf-family proteins and polynucleotides encoding the same
AU2001229517A1 (en) Human polynucleotides, polypeptides, and antibodies
AU2001255832A1 (en) Orfx polynucleotides and polypeptides